2nd Life Sciences Serialization & Traceability for Brand Protection

SUPPLY CHAIN STAKEHOLDERS RESPOND TO PROPOSED FDA TRACK AND TRACE GUIDANCE

The FDA is working with multiple industries and other countries to learn how to best implement pharmaceutical tracking and tracing within the United States. California is the first state to step up and set a deadline, but it is expected that the FDA will require a national ePedigree program to avoid all 50 states coming up with their own individual laws and deadlines in response to the precedent set by California.

If the US moved towards a federal track and trace system, how will pharmaceutical manufacturers repond to the implementation challenges they will face?

This May, ExL gathers high-level, global industry experts to provide unique take home solutions assisting organizations with the development of an efficient, economically-viable and secure end-to- end supply chain. After the success of helping life sciences’ executives gain perspective in this area at both the inaugural 2011 ExL US event, and at the subsequent European event, the following topics will be addressed in 2012's program:

• Maximizing ROI through your serialization and traceability initiatives
• Examining state and federal policy legislation
• The EFPIA proposal for a Pan-EU verification system of pharmaceutical products
• Building a global serialization infrastructure for the complete supply chain
• Initiating an industry-wide collaboration to achieve end-to-end supply chain visibility
• Preparing a compliant system of traceability that maximizes the business necessity 
for brand protection
• GS1’s healthcare standards enabling traceability
• Mass serialization for track and trace and ePedigree based on 2D matrix code
• Using GTINs for product identification on your products and in your supply chain 

Benefit from industry participation from Amylin Pharmaceuticals, Valeant Pharmaceuticals, Baxter Healthcare, Boehringer-Ingelheim, GS1 US, California Board of Pharmacy, EFPIA, Beckton Dickinson and many more serialization and traceability experts. Additionally, benchmark with other leading serialization and traceability experts and remain 100% competitive.

Testimonials from ExL's 2011 Serialization and Traceability Program 

"Very detailed examples and processes used”

GLOBAL PORTFOLIO DIRECTOR, MATERIALS, BRADY CORPORATION

“Excellent speakers and great information to share”

MANAGER, RX RETURNS, WALGREENS CO

“Excellent conference! Good depth and breadth of presentations!”

DIRECTOR, US OPERATIONS, GLAXOSMITHKLINE

“Excellent meeting! Great presentations, I really enjoyed it!”

SUPPLY CHAIN LEADER, BIO-RAD

“Great information! Good speakers, and a lot of good takeaways!”

- SENIOR ASSOCIATE, REGULATORY AFFAIRS, LABELING, COVIDIEN